Click here to read the latest top Canadian cannabis stocks list.
The marijuana stock market has held investors’ attention during 2019, even as sentiment adjusts and expectations for the industry change.
Companies have faced a volatile market this year, with a now recognized pullback dragging the space down. But while the overall sector has experienced a downturn, investors have still found opportunities for gains in the marijuana stock universe.
Read on to view the top cannabis gainers so far this year on the CSE, TSXV and TSX. All stats were current as of September 30, 2019; CSE and TSXV stocks listed had market caps between C$10 million and C$500 million at that time, and TSX stocks listed had market caps between C$1 billion and C$15 billion.
CSE top cannabis stocks
1. Captiva Verde Land (CSE:PWR)
This relative newcomer to the marijuana public sector started trading on the CSE in October 2018. It is a real estate company with investments in various areas, including cannabis operations.
While Captiva Verde Land did not have a quarter full of announcements, it did complete an acquisition of facilities that will help support the outdoor growing operations of its marijuana grower subsidiary Solargram Farms. The firm has indicated it is expecting a first harvest sometime in 2020 for both its indoor and outdoor cannabis product.
Shares of Captiva have risen 200 percent over a year-to-date period to reach a price of C$0.24.
2. Benchmark Botanics (CSE:BBT)
This cannabis company has operations in Canada and in Europe. Thank to its subsidiary Potanicals Green Growers, the firm holds a license for marijuana production in Peachland, British Columbia.
During the quarter, the company completed a new partnership with Zhejiang Yatai Pharmaceutical (SZSE:002370), a Chinese drugmaker. This partnership will produce a joint venture to “explore opportunities, subject to compliance with Canadian Cannabis Act and related Regulations, to cultivate, manufacture, process, and market high content cannabidiol cannabis products.”
Benchmark Botnics’ shares have risen 104.35 percent in value this year for a price of C$0.47.
3. Citation Growth (CSE:CGRO)
Formerly known as Liht Cannabis, this company manages marijuana assets in Nevada, Washington, California and British Columbia. During the third quarter, the firm conducted a critical merger with ACC Group of Companies, a Nevada cannabis cultivation operation.
“The acquisition of ACC provides the fuel required to accelerate Citation’s movement to large-scale cannabis cultivation and production,” Rahim Mohamed, president of Citation Growth, said in a statement. As part of the transaction, the public firm issued 35 million shares.
Citation faced a roadblock in October due to an error in the filing of its financial statement for the year ended on March 31, 2019. Three key amendments were made to the statement.
So far in 2019, shares of this firm have increased in value by 63.24 percent to rest at C$0.25.
TSXV top cannabis stocks
1. SugarBud Craft Growers (TSXV:SUGR)
During Q3, SugarBud Craft Growers obtained its cultivation, processing and medical sales licenses from Health Canada. This officially kicked off operations for the firm out of its facility in Stavely, Alberta.
“As a premium product provider, focused on quality, product leadership and customer satisfaction, we believe that the heart and soul of everything we do starts with what we grow,” John Kondrosky, CEO of the firm, said in a statement.
Due to the pullback in the cannabis market, the entire Canadian marijuana space saw a sharp decline in performance during the third quarter.
SugarBud Craft Growers was no stranger to this effect — although its share price is up only 12.5 percent to C$0.08, the company is the TSXV’s top-performing cannabis stock so far this year.
2. 48North (TSXV:NRTH)
48North issued its fiscal 2019 results in September, reporting net revenues of C$4.8 million. During the period, the company raised close to C$50 million for a cash position of C$52.7 million. However, the firm posted a net loss for the year of C$8.1 million.
So far this year, the company has seen an increase in value of 1.64 percent for a price of C$0.62.
TSX top cannabis stocks
1. Alcanna (TSX:CLIQ)
Alcanna manages the retail operations of Nova Cannabis and is associated with Canadian producer Aurora Cannabis (TSX:ACB,NYSE:ACB).
As part of its most recent quarterly update to investors, Alcanna said that a Nova Cannabis shop in Toronto, Ontario, has quickly gained the most volume of all its stores in the country. This store averages C$450,000 per week. Alcanna manages nine stores across Canada: eight in Alberta and one in Ontario.
Shares of Alcanna have grown by 20.9 percent so far this year, resulting in a price of C$5.20.
2. Charlotte’s Web Holdings (TSX:CWEB)
This hemp-derived cannabidiol (CBD) manufacturer has continued its path in the US by offering novelty products in high demand across the country.
This past quarter, the firm reported steady operational growth during Q2. During a call with investors, Deanie Elsner, CEO of Charlotte’s Web Holdings, said the firm is cautiously optimistic about the national conversation around CBD regulation with the US Food and Drug Administration (FDA).
“While the farm bill unlocked the door for category availability, the FDA now has the opportunity to expand availability of hemp CBD products across more distribution points to benefit more consumers,” Elsner said during the call.
Over a year-to-date period, shares of the CBD producer have risen 2.63 percent for a price of C$18.35.
3. HEXO (TSX:HEXO)
This Canadian marijuana producer joined a few of its peers by securing a listing on the New York Stock Exchange (NYSE) in July.
“We are extremely pleased to list on the NYSE and believe it reaffirms HEXO’s strong track-record for exceptional corporate governance and is further proof that we are a valuable cannabis industry partner for Fortune 500 companies,” CEO and Co-founder Sebastien St-Louis said in a statement.
Also in Q3, HEXO was able to increase the availability of its products in the Canadian market. In Alberta, the firm started selling its cannabis Elixir oral sprays, while in Ontario HEXO secured 18 new product variety listings with the provincial distributor, the Ontario Cannabis Store.
Shares of HEXO have scaled up 0.38 percent in value, resulting in a price per share of C$5.23.
Want more details? Check out these articles for more INNdepth coverage.
- Cannabis Investment: Canadian Cannabis Stocks
- Invest in Cannabis: TSX Cannabis Stocks
- Cannabis Companies: Stocks on the TSXV
- 10 Small Cap Cannabis Stocks
- 10 Big-cap Canadian Cannabis Stocks
- CSE Marijuana Stocks
- Cannabis stocks on the CSE25 Index
- Are Canadian Marijuana Stocks a Good Investment?
Want an overview of investing in cannabis stocks? Check Investing in the Cannabis Industry
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).